ACCOUNTS - Final Accounts

Creditors: Amounts falling due within one year

Registered number: 06340596

PROVERIS SCIENTIFIC UK LTD

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

PROVERIS SCIENTIFIC UK LTD

COMPANY INFORMATION

Directors	D. Farina
	R. Leveille


Registered number	06340596


Registered office	Ashtons Legal Trafalgar House
	4 Meridian Way
	Norwich
	NR7 0TA


Independent auditors	Wilder Coe Ltd
	Chartered Accountants & Statutory Auditors
	1st Floor Sackville House
	143-149 Fenchurch Street
	London
	EC3M 6BL

PROVERIS SCIENTIFIC UK LTD

REGISTERED NUMBER: 06340596

BALANCE SHEET

AS AT 31 DECEMBER 2025

		Unaudited
	2025	2024
Note	£	£


Current assets
Debtors	5	164,173		258,648
Cash at bank and in hand		171,403		38,163
		335,576		296,811
Creditors: amounts falling due within one year	6	(63,161)		(65,015)
Net assets			272,415		231,796

Capital and reserves
Allotted, called up and fully paid share capital	100	100
Profit and loss account	272,315	231,696
Equity shareholder's funds	272,415	231,796

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006
with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the Directors' Report and the Statement of Income and Retained Earnings in accordance with provisions applicable to companies subject to the small companies regime,under section 444
of the Companies Act 2006.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 2 September 2026.

R. Leveille

Director

The notes on pages 2 to 5 form part of these financial statements.

Page 1

PROVERIS SCIENTIFIC UK LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

1.	General information

Proveris Scientific UK Limited (registered number: 06340596), having its registered office and principal
place of business at Ashtons Legal Trafalgar House, 4 Meridian Way, Norwich, NR7 0TA, is a private
limited company incorporated in England and Wales.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

2.2

Statement of Cash Flows

The Company has taken advantage of the exemption in Financial Reporting Standard 102, Section 1A.7 from the requirement to provide a Statement of Cash Flows on the grounds that it is a small company.

2.3

Turnover

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

∙the amount of turnover can be measured reliably;

∙it is probable that the Company will receive the consideration due under the contract;

∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and

∙the costs incurred and the costs to complete the contract can be measured reliably.

Page 2

PROVERIS SCIENTIFIC UK LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Computer equipment

33.33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Income and Retained Earnings.

2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment.

2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

2.7

Creditors

Short-term creditors are measured at the transaction price.

2.8

Interest income

Interest income is recognised in the Statement of Income and Retained Earnings using the effective interest method.

2.9

Taxation

Tax is recognised in the Statement of Income and Retained Earnings.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date in the countries where the Company operates and generates income.

Employees

The average monthly number of employees, including directors, during the year was 6 (2024 - 6).

Page 3

PROVERIS SCIENTIFIC UK LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

4.	Tangible fixed assets

		Computer equipment
		£
	Cost
	At January 2025 and 31 December 2025	1,000
	Depreciation
	At January 2025 and 31 December 2025	1,000
	Net book value
	At 31 December 2025	-
	At 31 December 2024	-

Debtors

						Unaudited
					2025	2024
					£	£

Amounts due within one year
Amounts owed by group undertakings	158,691	253,200
Other debtors	482	448
Prepayments and accrued income	5,000	5,000
	164,173	258,648

Trade creditors	960	904
Corporation tax	15,810	15,965
Other taxation and social security	12,681	17,815
Accruals and deferred income	33,710	30,331
	63,161	65,015

7.	Related party transactions

The Company has taken advantage of the exemption in Financial Reporting Standard 102, Section 33.1A
not to disclose transactions with group entities which are wholly owned by a member of the group.

Page 4

PROVERIS SCIENTIFIC UK LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

8.	Immediate and ultimate parent undertaking

The Company's immediate parent undertaking at 31 December 2025 and 31 December 2024 was Proveris Scientific Corporation, a company incorporated in the United States of America.

The Company's ultimate parent undertaking was Proveris Scientific Corporation as at 31 December 2024. However as at 31 December 2025 the ultimate parent undertaking was Investindustrial Growth III SCSp.

The parent undertaking of the smallest and largest group, of which Proveris Scientific UK Ltd is a member and for which accounts are prepared, is Investindustrial Growth III SCSp, a company incorporated in the Luxembourg.

The consolidated accounts can be obtained from the following address:
11, Rue Aldringen
L-1118 Luxembourg
Luxembourg

9.	Auditors' information

The Company was subject to an audit for the year ended 31 December 2025. The audit report was issued with an unqualified opinion and signed on 04 September 2026 by Chris Gent BA FCA (Senior Statutory Auditor) on behalf of Wilder Coe Ltd.

Page 5